Next, in an effort to profile a ROS1+ specific expression signature, transcriptomes of ROS1+ tumor samples and ROS1+ patient-derived cell lines were compared to normal lung tissue or ALK/RET+ NSCLC specimens. This evidence concerns the gene RET and non-small cell lung carcinoma.